Close
CDMO Safety Testing 2026
Novotech

Medical Research Council Finds Antibody Capable of Fighting Flu

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Incyte Expands Haematology Portfolio with Vega Acquisition

Incyte has agreed to acquire Vega Therapeutics, a subsidiary...

GSK Targets Nuvalent in $10.6 Billion Oncology Acquisition

GSK has agreed to acquire Nuvalent in a transaction...

Firefly Bio Acquisition Strengthens J&J Cancer Pipeline

Johnson & Johnson (J&J) has entered into a definitive...
- Advertisement -

An antibody that can fight all types of the influenza A virus has been identified by researchers from the Medical Research Council’s National Institute for Medical Research.

Studies in fly-infected mice showed that the antibody could be used as an emergency treatment or in the development of a universal vaccine, rather than be used to create a new vaccine each winter. The antibody, named FI6, targets a protein found on the surface of the virus, called haemagglutinin. Mice infected with a lethal dose of the H1N1 virus were injected with the antibody two days after the virus was recorded and survived.

ย 

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Incyte Expands Haematology Portfolio with Vega Acquisition

Incyte has agreed to acquire Vega Therapeutics, a subsidiary...

GSK Targets Nuvalent in $10.6 Billion Oncology Acquisition

GSK has agreed to acquire Nuvalent in a transaction...

Firefly Bio Acquisition Strengthens J&J Cancer Pipeline

Johnson & Johnson (J&J) has entered into a definitive...

Daewoong and Chime Biologics Partner for Biosimilar Push

Chime Biologics and Daewoong Pharmaceutical have entered into a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป